Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
1.001
+0.001 (0.10%)
Apr 1, 2025, 10:42 AM EDT - Market open

Cytosorbents Statistics

Total Valuation

Cytosorbents has a market cap or net worth of $54.73 million. The enterprise value is $78.29 million.

Market Cap 54.73M
Enterprise Value 78.29M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

Cytosorbents has 54.68 million shares outstanding. The number of shares has increased by 21.18% in one year.

Current Share Class 54.68M
Shares Outstanding 54.68M
Shares Change (YoY) +21.18%
Shares Change (QoQ) +0.48%
Owned by Insiders (%) 14.42%
Owned by Institutions (%) 25.49%
Float 44.01M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.53
Forward PS 1.27
PB Ratio 4.94
P/TBV Ratio 4.92
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.20
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.20, with a Debt / Equity ratio of 2.42.

Current Ratio 2.20
Quick Ratio 1.08
Debt / Equity 2.42
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -12.00

Financial Efficiency

Return on equity (ROE) is -120.52% and return on invested capital (ROIC) is -26.36%.

Return on Equity (ROE) -120.52%
Return on Assets (ROA) -20.85%
Return on Invested Capital (ROIC) -26.36%
Return on Capital Employed (ROCE) -44.71%
Revenue Per Employee $191,368
Profits Per Employee -$111,392
Employee Count 186
Asset Turnover 0.71
Inventory Turnover 3.26

Taxes

Income Tax -1.69M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +5.26% in the last 52 weeks. The beta is 1.17, so Cytosorbents's price volatility has been higher than the market average.

Beta (5Y) 1.17
52-Week Price Change +5.26%
50-Day Moving Average 1.06
200-Day Moving Average 1.03
Relative Strength Index (RSI) 44.03
Average Volume (20 Days) 86,912

Short Selling Information

The latest short interest is 1.84 million, so 3.37% of the outstanding shares have been sold short.

Short Interest 1.84M
Short Previous Month 1.85M
Short % of Shares Out 3.37%
Short % of Float 4.19%
Short Ratio (days to cover) 12.56

Income Statement

In the last 12 months, Cytosorbents had revenue of $35.59 million and -$20.72 million in losses. Loss per share was -$0.38.

Revenue 35.59M
Gross Profit 25.13M
Operating Income -16.79M
Pretax Income -28.35M
Net Income -20.72M
EBITDA -15.22M
EBIT -16.79M
Loss Per Share -$0.38
Full Income Statement

Balance Sheet

The company has $3.28 million in cash and $26.89 million in debt, giving a net cash position of -$23.61 million or -$0.43 per share.

Cash & Cash Equivalents 3.28M
Total Debt 26.89M
Net Cash -23.61M
Net Cash Per Share -$0.43
Equity (Book Value) 11.11M
Book Value Per Share 0.20
Working Capital 11.78M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.43 million and capital expenditures -$284,343, giving a free cash flow of -$14.71 million.

Operating Cash Flow -14.43M
Capital Expenditures -284,343
Free Cash Flow -14.71M
FCF Per Share -$0.27
Full Cash Flow Statement

Margins

Gross margin is 70.59%, with operating and profit margins of -47.16% and -58.21%.

Gross Margin 70.59%
Operating Margin -47.16%
Pretax Margin -62.96%
Profit Margin -58.21%
EBITDA Margin -42.75%
EBIT Margin -47.16%
FCF Margin n/a

Dividends & Yields

Cytosorbents does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -21.18%
Shareholder Yield n/a
Earnings Yield -37.89%
FCF Yield -26.91%

Analyst Forecast

The average price target for Cytosorbents is $4.67, which is 366.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.67
Price Target Difference 366.53%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) 42.83%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on December 5, 2014. It was a reverse split with a ratio of 0.04:1.

Last Split Date Dec 5, 2014
Split Type Reverse
Split Ratio 0.04:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1